Why Yale Medicine?
- Pathology team with extensive, sub-specialized expertise in pathway genomics
- Daily multidisciplinary conferences to evaluate complex diagnoses, incorporating cutting-edge research
- Emphasis on tried-and-tested techniques
By quickly and inexpensively sequencing an individual's entire genome, pathologists can identify mutations that cause particular types of cancer. This information helps doctors create custom treatments. This new capability is sometimes called precision medicine or personalized medicine. It has given rise to a new discipline within the medical field, genomic pathology—an area where Yale Medicine has exceptional expertise.
Keywords in this article:
Cancer Risk Assessment, Cancer Genomics, Head and Neck Cancer Genomics, Lung Cancer Genomics, Bladder Cancer Genomics, Brain Cancer Genomics, Breast Cancer Genetics, Cervical Cancer Genomics, Colon Cancer Genomics, Genitourinary Cancer Genomics, Gynecologic Cancer Genomics, Gastrointestinal Cancer Genomics, Leukemia Genomics, Liver Cancer Genomics, Lymphoma Genomics, Melanoma Genomics, Pancreatic Cancer Genomics, Prostate Cancer Genomics, Rectal Cancer Genomics, Renal Cancer Genomics, Skin Cancer Genomics, Stomach Cancer Genomics, Thyroid Cancer Genomics, Gallbladder Cancer Genomics, Sarcoma Genomics
Clinical Trials
New treatments for many conditions are tested in clinical trials, which ultimately bring
lifesaving new drugs and devices to the patients who need them most.
By participating in a clinical trial, you may get access to the most advanced treatments
for your condition, and help determine their benefits for future patients.
